| |
Total N = 255 (%)
|
IC N = 169 (%)
|
MID N = 43 (%)
|
SID N = 43 (%)
|
P value
|
|---|
|
Demographic data
|
|
Sex (male)
|
160 (62.7)
|
113 (66.9)
|
24 (54.5)
|
23 (54.8)
|
0.162
|
|
Age (y)
|
46.6 ± 13.7
|
46.4 ± 12.8
|
51.8 ± 14.4
|
41.9 ± 14.9
|
< 0.001 (#)
|
|
BMI, kg/m2
|
23.3 ± 3.3
|
23.8 ± 3.0
|
24.3 ± 3.4
|
20.2 ± 2.4
|
< 0.001 (*)
|
|
Contact history
|
16 (6.3)
|
12 (7.1)
|
3 (7.0)
|
1 (2.3)
|
0.504
|
|
Time since diagnosis(d)
|
30.0 (14.3, 60.0)
|
30.0 (15.0, 60.0)
|
30.0 (22.0, 60.0)
|
17.5 (9.0, 30.0)
|
< 0.001 (*)
|
|
Dissemination
|
57 (22.4)
|
17 (10.1)
|
8 (18.6)
|
32 (74.4)
|
< 0.001 (*)
|
|
Medical history
|
|
Diabetes 13 (6.4) 8 (14.6) 0.06
|
25 (9.8)
|
0
|
20 (46.5)
|
5 (11.6)
| |
|
Glucocorticoid 38 (69.1)
|
42 (16.5)
|
0
|
11 (25.6)
|
31 (72.1)
| |
|
Liver dysfunction
|
11 (4.3)
|
0
|
8 (18.6)
|
3 (7.0)
| |
|
Chemotherapy 05 (9.1)
|
6 (2.4)
|
0
|
6 (14.0)
|
0
| |
|
Autoimmune diseases 0 27 (49.1)
|
18 (7.1)
|
0
|
6 (14.0)
|
12 (27.9)
| |
|
Other renal disease 1 (0.5) 4 (7.3)
|
8 (3.1)
|
0
|
2 (4.7)
|
6 (14.0)
| |
|
Haemopathy
|
6 (2.4)
|
0
|
1 (2.3)
|
5 (11.2)
| |
|
AIDS 08 (14.6)
|
8 (3.1)
|
0
|
0
|
8 (18.6)
| |
|
Kidney transplant 013 (23.6)
|
13 (5.1)
|
0
|
0
|
13 (30.2)
| |
|
Immunosuppressant
|
31 (12.2)
|
0
|
0
|
31 (72.1)
| |
- Haemopathy included myelodysplastic syndrome (MDS, n = 2), allergic purpura (n = 1), multiple myeloma (MM, n = 1), lymphoma (n = 1), and haemolytic anaemia (HA, n = 1); Autoimmune diseases included systemic lupus erythematosus (SLE, n = 10), rheumatoid arthritis (RA, n = 3), connective tissue disease (CTD, n = 1), sarcoidosis (n = 1), ankylosing spondylitis (AS, n = 1), Hashimoto thyroiditis (HT, n = 1), and pemphigoid (n = 1); Other renal diseases included nephrotic syndrome (NS, n = 6), IgA nephropathy (IgAN, n = 1), and renal cell carcinoma (RCC, n = 1); Liver dysfunction included hepatic cirrhosis (n = 9) and hepatocellular carcinoma (HCC, n = 2)
- BMI, body mass index; *SID vs. IC/MID; #MID vs. IC/SID;
